Synthesis and anticancer activity of bis(2-arylimidazo[1,2-
anticancer activity
copper catalyst
diselenide
imidazopyridine
selenide
selenium
Journal
Beilstein journal of organic chemistry
ISSN: 1860-5397
Titre abrégé: Beilstein J Org Chem
Pays: Germany
ID NLM: 101250746
Informations de publication
Date de publication:
2020
2020
Historique:
received:
29
02
2020
accepted:
04
05
2020
entrez:
20
6
2020
pubmed:
20
6
2020
medline:
20
6
2020
Statut:
epublish
Résumé
Most heteroaryl selenides and diselenides are biologically active, with some reported to act as antioxidants and show activities that are medicinally relevant; hence, the development of efficient methods for their synthesis is an important objective. Herein, a simple method for the synthesis of selenides and diselenides bearing imidazo[1,2-
Identifiants
pubmed: 32550922
doi: 10.3762/bjoc.16.94
pmc: PMC7277930
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1075-1083Informations de copyright
Copyright © 2020, Matsumura et al.; licensee Beilstein-Institut.
Références
Chem Rev. 2004 Dec;104(12):6255-85
pubmed: 15584701
J Med Chem. 2011 Nov 10;54(21):7705-12
pubmed: 21955208
Chem Pharm Bull (Tokyo). 1991 Nov;39(11):2937-43
pubmed: 1799940
J Med Chem. 2008 Nov 27;51(22):7243-52
pubmed: 18973287
Acc Chem Res. 2014 Oct 21;47(10):2985-98
pubmed: 25248146
Curr Cancer Drug Targets. 2011 May;11(4):496-523
pubmed: 21395545
Curr Top Med Chem. 2016;16(30):3590-3616
pubmed: 27086790
Org Biomol Chem. 2008 Mar 21;6(6):965-74
pubmed: 18327317
Mini Rev Med Chem. 2007 Sep;7(9):888-99
pubmed: 17897079
Chem Rev. 2010 Jul 14;110(7):4357-416
pubmed: 20384363
Chem Rev. 2001 Jul;101(7):2125-79
pubmed: 11710243
Org Biomol Chem. 2005 Apr 21;3(8):1541-6
pubmed: 15827654
J Med Chem. 2004 Feb 12;47(4):947-61
pubmed: 14761196
Molecules. 2018 Mar 10;23(3):
pubmed: 29534447
Chem Asian J. 2014 Jan;9(1):237-44
pubmed: 24347073
Arch Toxicol. 2011 Nov;85(11):1313-59
pubmed: 21720966
J Med Chem. 1998 Nov 5;41(23):4587-98
pubmed: 9804698